Table 2.
Factor | 5 years risk of metastases | HR | 95% CI | P value |
---|---|---|---|---|
Overall | 34% | |||
| ||||
Depth: | ||||
Superficial | 28% | 1 | ||
Deep | 37% | 1.443 | 0.68–3.07 | 0.341 |
| ||||
Size: | ||||
Up to 5 cm | 22% | 0.771 | 0.24–2.52 | 0.667 |
> 5 cm to <10 cm | 28% | 0.69 | 0.38–1.27 | 0.232 |
>10 cm | 38% | 1 | ||
| ||||
Site: | ||||
Lower extremity | 33% | 0.889 | 0.22–3.66 | 0.871 |
Upper extremity | 40% | 1 | ||
Trunk | 20% | 0.780 | 0.07–8.68 | 0.84 |
| ||||
Histology: | ||||
Pure myxoid | 8% | 1 | ||
0–5% round cell | 35% | 4.166 | 1.36–12.78 | 0.0126 |
>5% round cell | 54% | 8.899 | 3.35–23.64 | <0.0001 |
| ||||
Margin: | ||||
Intralesional | 55% | 1.347 | 0.61–2.96 | 0.459 |
Marginal | 26% | 0.722 | 0.39–1.31 | 0.286 |
Wide | 37% | 1 | ||
| ||||
Surgery: | ||||
Amputation | 73% | 3.091 | 1.546–6.179 | 0.0014 |
Limb salvage | 29% | 1 | ||
| ||||
Postoperative radiotherapy | 28% | 0.725 | 0.38–1.38 | 0.329 |
No radiotherapy | 36% | 1 |